Table 3 Prevalences determined using the microscopic Kato-Katz method, the POC-CCA rapid diagnostic test and serum-based real-time PCR 20 weeks after therapy with praziquantel
Method | Cases/Total | % |
|---|---|---|
Microscopy (Kato-Katz) | 0/36 | 0 |
POC-CCA | 12/36 | 33.3 |
Serum real-time PCR | 21/36 | 58.3 |